Cognition Therapeutics Stock (NASDAQ: CGTX) stock price, news, charts, stock research, profile.
You can purchase shares of Cognition Therapeutics (NASDAQ:CGTX) through any online brokerage.
Other companies in Cognition Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP) and SCYNEXIS (NASDAQ:SCYX).
Cognition Therapeutics has a consensus price target of $7.92.
The stock price for Cognition Therapeutics (NASDAQ: CGTX) is $0.7622 last updated January 22, 2025 at 5:00 AM EST.
There are no upcoming dividends for Cognition Therapeutics.
Cognition Therapeutics’s Q4 earnings are confirmed for Tuesday, March 25, 2025.
There is no upcoming split for Cognition Therapeutics.
Cognition Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.